Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
383
datasets available to search
ShareScore release 0.9.0
Dataset results
383 results for “GVHD”
Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis
ClinicalTrials.gov study NCT01860170. IPD Sharing: NO. Countries: 1. Publications: 0.
Exploratory Safety Study of ALD518 in Subjects With Steroid-refractory Acute Graft Versus Host Disease (GVHD)
ClinicalTrials.gov study NCT01530256. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of orBec® as Monotherapy in the Treatment of Patients With Upper GI Symptoms Caused by Chronic Graft Versus Host Disease (GVHD)
ClinicalTrials.gov study NCT01925950. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients
ClinicalTrials.gov study NCT02877082. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD
ClinicalTrials.gov study NCT02652130. IPD Sharing: NO. Countries: 1. Publications: 0.
Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant
ClinicalTrials.gov study NCT00639717. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myeloablative Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-005)
ClinicalTrials.gov study NCT04095858. IPD Sharing: YES. Countries: 1. Publications: 0.
Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell T
ClinicalTrials.gov study NCT04339101. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant
ClinicalTrials.gov study NCT05675930. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)
ClinicalTrials.gov study NCT01757197. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD
ClinicalTrials.gov study NCT01163786. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Identification of Novel Targetable Kinases in SR-a GvHD
ClinicalTrials.gov study NCT04342442. IPD Sharing: NO. Countries: 0. Publications: 4.
Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies
ClinicalTrials.gov study NCT01789255. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetics-based Mycophenolate Mofetil Dosing for GVHD Prevention
ClinicalTrials.gov study NCT01487577. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effect of Folinic Acid Rescue Following MTX GVHD Prophylaxis on Regimen Related Toxicity and Transplantation Outcome
ClinicalTrials.gov study NCT02506231. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
ClinicalTrials.gov study NCT05236062. IPD Sharing: YES. Countries: 1. Publications: 0.
Maraviroc as GVHD Prophylaxis in Transplant Recipients
ClinicalTrials.gov study NCT02167451. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Acute Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Stem-Cell Transplantation
ClinicalTrials.gov study NCT02737306. IPD Sharing: NO. Countries: 1. Publications: 0.
Ruxolitinib as GVHD Prophylaxis in AA Patients
ClinicalTrials.gov study NCT05914714. IPD Sharing: NO. Countries: 0. Publications: 0.
In-Vivo Activated T-Cell Depletion to Prevent GVHD
ClinicalTrials.gov study NCT00594308. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.